Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Cortesi

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Tumori|April 5, 2021
Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter studyMaria Bassanelli, Biagio Ricciuti, Diana Giannarelli, et al.
Breast Cancer Research and Treatment|March 3, 2007
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer familiesAmelia Buffone, Carlo Capalbo, Enrico Ricevuto, et al.
Frontiers in Oncology|January 30, 2023
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities managementMichela Roberto, Martina Panebianco, Anna Maria Aschelter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 17, 2010
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapyFlavia Longo, Giovanni Mansueto, Vittoria Lapadula, et al.
Journal of Translational Medicine|March 24, 2021
The role of opioids in cancer response to immunotherapyAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Andrology|July 30, 2024
Testicular ultrasonographic features predict future risk for bilateral testicular germ cell tumour: A long-term single centre follow-up studyMarta Tenuta, Paola Mazzotta, Franz Sesti, et al.
Clinical Lung Cancer|May 10, 2011
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutationsGabriella Farina, Flavia Longo, Olga Martelli, et al.
Critical Reviews in Oncology/Hematology|April 15, 2023
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectivesCatia Carconi, Micaela Cerreti, Michela Roberto, et al.
The Oncologist|April 13, 2013
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinomaLorenza Rimassa, Tiziana Pressiani, Corrado Boni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamidePaola Papaldo, Massimo Lopez, Paolo Marolla, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Tumori|April 5, 2021
Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter studyMaria Bassanelli, Biagio Ricciuti, Diana Giannarelli, et al.
Breast Cancer Research and Treatment|March 3, 2007
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer familiesAmelia Buffone, Carlo Capalbo, Enrico Ricevuto, et al.
Frontiers in Oncology|January 30, 2023
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities managementMichela Roberto, Martina Panebianco, Anna Maria Aschelter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 17, 2010
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapyFlavia Longo, Giovanni Mansueto, Vittoria Lapadula, et al.
Journal of Translational Medicine|March 24, 2021
The role of opioids in cancer response to immunotherapyAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Andrology|July 30, 2024
Testicular ultrasonographic features predict future risk for bilateral testicular germ cell tumour: A long-term single centre follow-up studyMarta Tenuta, Paola Mazzotta, Franz Sesti, et al.
Clinical Lung Cancer|May 10, 2011
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutationsGabriella Farina, Flavia Longo, Olga Martelli, et al.
Critical Reviews in Oncology/Hematology|April 15, 2023
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectivesCatia Carconi, Micaela Cerreti, Michela Roberto, et al.
The Oncologist|April 13, 2013
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinomaLorenza Rimassa, Tiziana Pressiani, Corrado Boni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamidePaola Papaldo, Massimo Lopez, Paolo Marolla, et al.
Pageof 18